Proteomics

Dataset Information

0

Syndecan liver cancer nanoHPLC-MS/MS results


ABSTRACT: Liver cancer was induced in mouse model organisms with diethylnitrosamine. It was found the the introduction of human Syndecan significantly slowed down the carcinogenesis. The proteomic profile of the syndecan treated livers proved to be significantly different from the non-treated samples. Details are shown in the paper.

INSTRUMENT(S): maXis

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

SUBMITTER: Lilla Turiak  

PROVIDER: MSV000086679 | MassIVE | Sat Jan 09 12:35:00 GMT 2021

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1
altmetric image

Publications


Although syndecan-1 (SDC1) is known to be dysregulated in various cancer types, its implication in tumorigenesis is poorly understood. Its effect may be detrimental or protective depending on the type of cancer. Our previous data suggest that SDC1 is protective against hepatocarcinogenesis. To further verify this notion, human SDC1 transgenic (hSDC1<sup>+/+</sup>) mice were generated that expressed hSDC1 specifically in the liver under the control of the albumin promoter. Hepatocarcinogenesis wa  ...[more]

Similar Datasets

2015-09-07 | PXD002578 | Pride
2018-03-29 | GSE97170 | GEO
2019-07-08 | PXD011458 | Pride
2016-05-31 | E-GEOD-73911 | biostudies-arrayexpress
2016-05-31 | GSE73911 | GEO
2014-02-27 | E-GEOD-55378 | biostudies-arrayexpress
2019-11-01 | PXD007285 | Pride
2019-03-14 | PXD010759 | Pride
2023-06-07 | PXD041465 | Pride
2008-12-09 | PRD000797 | Pride